Shiseido Company, Limited - 4911.T

4911.T Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
4911.T	3.5	1.5	-6.1	-23.9	-43.8	-35.0	-55.1	-66.7	49.2	74.4
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 4911.T with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	4911.T
name	Shiseido Company, Limited
price	2595
changes percentage	3.5102
change	88
day low	2533.5
day high	2609
year high	5272
year low	2495
market cap	1036501654785
price avg 50	2755.66
price avg 200	3775.825
exchange	JPX
volume	4511000
avg volume	3022998
open	2557
previous close	2507
eps	5.03
pe	515.9
earnings announcement	2025-02-10T06:00:00.000+0000
shares outstanding	399422603
timestamp	2025-01-17 06:45:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 41.3%

Overall Quarterly Financial Health: 85.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	973038000000	1067355000000	-8.84
gross profit	713364000000	744164000000	-4.14
gross profit ratio	0.73	0.7	5.15
research and development expenses	0	26678000000	-100.00
operating expenses	685378000000	697591000000	-1.75
interest income	6734000000	5877000000	14.58
interest expense	3674000000	3627000000	1.30
ebitda	106460000000	127234000000	-16.33
ebitdaratio	0.11	0.12	-10.01
operating income	28133000000	46572000000	-39.59
operating income ratio	0.03	0.04	-33.74
net income	21749000000	34202000000	-36.41
net income ratio	0.02	0.03	-30.25
eps	54.42	85.6	-36.43

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 973,038 million in 2023 from 1,067,355 million in 2022 representing a change of -8.84%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 685,378 million in 2023 from 697,591 million in 2022 representing a change of -1.75%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 713,364 million in 2023 from 744,164 million in 2022 representing a change of -4.14%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 26,678 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 106,460 million in 2023 from 127,234 million in 2022 representing a change of -16.33%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 28,133 million in 2023 from 46,572 million in 2022 representing a change of -39.59%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 21,749 million in 2023 from 34,202 million in 2022 representing a change of -36.41%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 54.42 in 2023 from 54.42 in 2022 representing a change of -36.43%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	259083000000	249453000000	3.86
gross profit	197930000000	187517000000	5.55
gross profit ratio	0.76	0.75	1.63
research and development expenses	6800000000	6700000000	1.49
operating expenses	191914000000	196520000000	-2.34
interest income	2777000000	4403000000	-36.93
interest expense	1108000000	962000000	15.18
ebitda	27421000000	14485000000	89.31
ebitdaratio	0.11	0.04	168.78
operating income	6016000000	-9003000000	166.82
operating income ratio	0.02	-0.04	164.34
net income	3302000000	-3285000000	200.52
net income ratio	0.01	-0.01	196.78
eps	8.26	-8.22	200.49

Overall Score of Quarterly Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 259,083 million in 2024Q2 from 249,453 million in 2024Q1 representing a change of 3.86%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 197,930 million in 2024Q2 from 187,517 million in 2024Q1 representing a change of 5.55%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 6,800 million in 2024Q2 from 6,700 million in 2024Q1 representing a change of 1.49%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 191,914 million in 2024Q2 from 196,520 million in 2024Q1 representing a change of -2.34%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 27,421 million in 2024Q2 from 14,485 million in 2024Q1 representing a change of 89.31%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 6,016 million in 2024Q2 from -9,003 million in 2024Q1 representing a change of 166.82%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3,302 million in 2024Q2 from -3,285 million in 2024Q1 representing a change of 200.52%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 8.26 in 2024Q2 from 8.26 in 2024Q1 representing a change of 200.49%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1255497000000	1307661000000	-3.99
total liabilities	615105000000	681908000000	-9.80
total equity	640392000000	625753000000	2.34
cash and cash equivalents	104685000000	119036000000	-12.06
short term investments	21956000000	18498000000	18.69
long term investments	86426000000	81738000000	5.74
total current assets	470014000000	524229000000	-10.34
total non current assets	785483000000	783432000000	0.26
total current liabilities	368345000000	389562000000	-5.45
total non current liabilities	246760000000	292346000000	-15.59
common stock	64506000000	64506000000	0.00
retained earnings	380208000000	394877000000	-3.71
total debt	280981000000	297188000000	-5.45

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,255,497 million in 2023 from 1,307,661 million in 2022 representing a change of -3.99%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 104,685 million in 2023 from 119,036 million in 2022 representing a change of -12.06%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 470,014 million in 2023 from 524,229 million in 2022 representing a change of -10.34%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 380,208 million in 2023 from 394,877 million in 2022 representing a change of -3.71%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 615,105 million in 2023 from 681,908 million in 2022 representing a change of -9.8%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 640,392 million in 2023 from 625,753 million in 2022 representing a change of 2.34%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 21,956 million in 2023 from 18,498 million in 2022 representing a change of 18.69%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 368,345 million in 2023 from 389,562 million in 2022 representing a change of -5.45%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 280,981 million in 2023 from 297,188 million in 2022 representing a change of -5.45%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	1350040000000	1346308000000	0.28
total liabilities	668293000000	694994000000	-3.84
total equity	681747000000	651311000000	4.67
cash and cash equivalents	91857000000	90380000000	1.63
short term investments	24582000000	23363000000	5.22
long term investments	107539000000	120198000000	-10.53
total current assets	482231000000	478202000000	0.84
total non current assets	867809000000	868106000000	-0.03
total current liabilities	420271000000	449517000000	-6.51
total non current liabilities	248022000000	245477000000	1.04
common stock	64506000000	64506000000	0.00
retained earnings	368483000000	364960000000	0.97
total debt	315182000000	341861000000	-7.80

Overall Score of Quarterly Balance Sheet

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,350,040 million in 2024Q2 from 1,346,308 million in 2024Q1 representing a change of 0.28%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 668,293 million in 2024Q2 from 694,994 million in 2024Q1 representing a change of -3.84%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 681,747 million in 2024Q2 from 651,311 million in 2024Q1 representing a change of 4.67%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 91,857 million in 2024Q2 from 90,380 million in 2024Q1 representing a change of 1.63%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 24,582 million in 2024Q2 from 23,363 million in 2024Q1 representing a change of 5.22%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 482,231 million in 2024Q2 from 478,202 million in 2024Q1 representing a change of 0.84%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 420,271 million in 2024Q2 from 449,517 million in 2024Q1 representing a change of -6.51%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 368,483 million in 2024Q2 from 364,960 million in 2024Q1 representing a change of 0.97%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 315,182 million in 2024Q2 from 341,861 million in 2024Q1 representing a change of -7.8%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-14351000000	-37467000000	61.70
operating cash flow	89026000000	46735000000	90.49
free cash flow	33351000000	-19469000000	271.30
capital expenditure	-55675000000	-66204000000	15.90
depreciation and amortization	75492000000	75718000000	-0.30
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-23690000000	-12516000000	-89.28
inventory	-2223000000	-3348000000	33.60
acquisitions net	6868000000	13778000000	-50.15
investments in property plant and equipment	-26703000000	-66204000000	59.67
net cash used for investing activites	-35536000000	-41308000000	13.97
debt repayment	-5443000000	4343000000	-225.33
common stock issued	0	244000000	-100.00
common stock repurchased	-8000000	-9000000	11.11
dividends paid	-41908000000	-21969000000	-90.76
net cash used provided by financing activities	-75642000000	-52418000000	-44.31
cash at end of period	104685000000	119036000000	-12.06
accounts receivables	35142000000	-6334000000	654.82
cash at beginning of period	119036000000	156503000000	-23.94

Overall Score of Annual Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -14,351 million in 2023 from -37,467 million in 2022 representing a change of 61.7%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 89,026 million in 2023 from 46,735 million in 2022 representing a change of 90.49%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 33,351 million in 2023 from -19,469 million in 2022 representing a change of 271.3%. This indicates an increase in cash generated after accounting for capital expenditures.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -55,675 million in 2023 from -66,204 million in 2022 representing a change of 15.9%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 23,690 million in 2023 from 12,516 million in 2022 representing a change of -89.28%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 35,142 in 2023 from -6,334 million in 2022 representing a change of 654.82%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -41,908 million in 2023 from -21,969 million in 2022 representing a change of -90.76%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	28054000000	3557000000	688.70
free cash flow	16569000000	-9787000000	269.30
capital expenditure	-11485000000	-13344000000	13.93
depreciation and amortization	18627000000	18826000000	-1.06
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	11930000000	-19193000000	162.16
accounts payables	-22038000000	-7577000000	-190.85
inventory	-2328000000	1546000000	-250.58
acquisitions net	2427000000	-49207000000	104.93
investments in property plant and equipment	-11485000000	-13344000000	13.93
net cash used for investing activites	4338000000	-63401000000	106.84
debt repayment	-26572000000	60044000000	-144.25
common stock issued	0	0	NaN
common stock repurchased	-1000000	-1000000	0.00
dividends paid	-429000000	-11558000000	96.29
net cash used provided by financing activities	-35274000000	41761000000	-184.47
net change in cash	1477000000	-14305000000	110.33
cash at end of period	91857000000	90380000000	1.63
cash at beginning of period	90380000000	104685000000	-13.66

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,477 million in 2024Q2 from -14,305 million in 2024Q1 representing a change of 110.33%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 28,054 million in 2024Q2 from 3,557 million in 2024Q1 representing a change of 688.7%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 16,569 million in 2024Q2 from -9,787 million in 2024Q1 representing a change of 269.3%. This indicates an increase in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid increased to -429 million in 2024Q2 from -11,558 million in 2024Q1 representing a change of 96.29%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -11,485 million in 2024Q2 from -13,344 million in 2024Q1 representing a change of 13.93%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 22,038 million in 2024Q2 from 7,577 million in 2024Q1 representing a change of -190.85%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 11,930 in 2024Q2 from -19,193 million in 2024Q1 representing a change of 162.16%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q3 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	2434.94	2671.47	-8.85
net income per share	54.42	85.6	-36.42
operating cash flow per share	222.78	116.97	90.45
free cash flow per share	83.46	-48.73	271.27
cash per share	316.91	344.23	-7.94
book value per share	1602.52	1566.19	2.32
tangible book value per share	1102.53	1112.93	-0.93
shareholders equity per share	1548.36	1512.39	2.38
interest debt per share	712.32	752.91	-5.39
market cap	1699162980000	2585410398000	-34.28
enterprise value	1875458980000	2763562398000	-32.14
pe ratio	78.13	75.59	3.35
price to sales ratio	1.75	2.42	-27.91
pocfratio	19.09	55.32	-65.50
pfcf ratio	50.95	-132.8	138.37
pb ratio	2.75	4.28	-35.82
ptb ratio	2.75	4.28	-35.82
ev to sales	1.93	2.59	-25.56
enterprise value over ebitda	17.62	21.72	-18.89
ev to operating cash flow	21.07	59.13	-64.37
ev to free cash flow	56.23	-141.95	139.62
earnings yield	0.01	0.01	-3.24
free cash flow yield	0.02	-0.01	360.65
debt to equity	0.45	0.49	-7.67
debt to assets	0.22	0.23	-1.53
net debt to ebitda	1.66	1.4	18.27
current ratio	1.28	1.35	-5.18
interest coverage	7.66	12.84	-40.37
income quality	2.87	0.93	209.50
dividend yield	0.02	0.01	190.26
payout ratio	1.93	0.64	199.98
sales general and administrative to revenue	0.72	0.68	5.88
research and ddevelopement to revenue	0	0.02	-100.00
intangibles to total assets	0.16	0.14	14.92
capex to operating cash flow	0.63	1.42	-55.85
capex to revenue	0.06	0.06	-7.75
capex to depreciation	0.74	0.87	-15.65
stock based compensation to revenue	0	0	NaN
graham number	1376.97	1706.75	-19.32
roic	0.02	0.04	-36.28
return on tangible assets	0.02	0.03	-32.14
graham net net	-754.16	-856.87	11.99
working capital	101669000000	134667000000	-24.50
tangible asset value	440586000000	444657000000	-0.92
net current asset value	-145091000000	-157679000000	7.98
invested capital	703861000000	748378000000	-5.95
average receivables	165878500000	164576000000	0.79
average payables	68160000000	135579000000	-49.73
average inventory	140294000000	137350000000	2.14
days sales outstanding	56.15	62.26	-9.82
days payables outstanding	96.82	76.16	27.12
days of inventory on hand	210.34	147.88	42.24
receivables turnover	6.5	5.86	10.88
payables turnover	3.77	4.79	-21.33
inventory turnover	1.74	2.47	-29.70
roe	0.04	0.06	-37.90
capex per share	139.32	165.7	-15.92

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2023-12-31 from 0.06 on 2022-12-31, representing a change of -37.90%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 78.13 on 2023-12-31 from 75.59 on 2022-12-31, representing a change of 3.35%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.45 on 2023-12-31 from 0.49 on 2022-12-31, representing a change of -7.67%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.28 on 2023-12-31 from 1.35 on 2022-12-31, representing a change of -5.18%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
4911.T
calendar year	2024	2024	NaN
revenue per share	648.23	624.16	3.86
net income per share	8.26	-8.22	200.51
operating cash flow per share	70.19	8.9	688.66
free cash flow per share	41.46	-24.49	269.29
cash per share	291.33	284.6	2.37
book value per share	1705.74	1629.67	4.67
tangible book value per share	987.14	944.25	4.54
shareholders equity per share	1653.26	1574.67	4.99
interest debt per share	791.36	857.79	-7.74
market cap	1842520190000	1668180840000	10.45
enterprise value	2065845190000	1919661840000	7.62
pe ratio	139.5	-126.95	209.88
price to sales ratio	7.11	6.69	6.35
pocfratio	65.68	468.99	-86.00
pfcf ratio	111.2	-170.45	165.24
pb ratio	2.79	2.65	5.20
ptb ratio	2.79	2.65	5.20
ev to sales	7.97	7.7	3.62
enterprise value over ebitda	75.34	132.53	-43.15
ev to operating cash flow	73.64	539.69	-86.36
ev to free cash flow	124.68	-196.14	163.57
earnings yield	0.0	-0.0	191.01
free cash flow yield	0.01	-0.01	253.28
debt to equity	0.48	0.54	-12.19
debt to assets	0.23	0.25	-8.06
net debt to ebitda	8.14	17.36	-53.09
current ratio	1.15	1.06	7.86
interest coverage	5.43	-9.36	158.02
income quality	8.5	-1.08	884.64
dividend yield	0.0	0.01	-96.64
payout ratio	0.13	-3.52	103.69
sales general and administrative to revenue	0.74	0.79	-5.89
research and ddevelopement to revenue	0.03	0.03	-2.28
intangibles to total assets	0.21	0.2	4.56
capex to operating cash flow	0.41	3.75	-89.09
capex to revenue	0.04	0.05	-17.13
capex to depreciation	0.62	0.71	-13.01
stock based compensation to revenue	0	0	NaN
graham number	554.36	539.65	2.73
roic	0.0	-0.01	131.66
return on tangible assets	0.0	-0.0	201.42
graham net net	-880.42	-945.6	6.89
working capital	61960000000	28685000000	116.00
tangible asset value	394538000000	377380000000	4.55
net current asset value	-186062000000	-216792000000	14.17
invested capital	748214000000	702573000000	6.50
average receivables	160720500000	168863500000	-4.82
average payables	157266000000	173172500000	-9.19
average inventory	162220500000	153411500000	5.74
days sales outstanding	53.88	60.01	-10.20
days payables outstanding	215.92	243.86	-11.46
days of inventory on hand	246.17	228.4	7.78
receivables turnover	1.67	1.5	11.36
payables turnover	0.42	0.37	12.94
inventory turnover	0.37	0.39	-7.22
roe	0.0	-0.01	195.73
capex per share	28.74	33.39	-13.94

• Negative

  ROE: Return on Equity (ROE) increased to 0.00 on 2024-06-30 Q2 from -0.01 on 2024-03-31 Q1, representing a change of 195.73%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 139.50 on 2024-06-30 Q2 from -126.95 on 2024-03-31 Q1, representing a change of 209.88%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.15 on 2024-06-30 Q2 from 1.06 on 2024-03-31 Q1, representing a change of 7.86%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.48 on 2024-06-30 Q2 from 0.54 on 2024-03-31 Q1, representing a change of -12.19%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is -384.8 which is lower than current price 2595, indicates the company may be overvalued.